Amgen acquires Dark Blue Therapeutics for up to $840 million, adding early-stage leukemia drug research and strengthening its oncology discovery pipeline.

Researchers of the Hospital Universitario 12 de Octubre in Madrid and the Josep Carreras Leukaemia Research Institute have developed a cell therapy for a type of leukemia which currently has very few ...

Acute promyelocytic leukaemia (APL) represents a unique and once highly fatal subtype of acute myeloid leukaemia that is now considered among the most curable forms of haematological malignancies.

A common ingredient in some foods and drinks has been linked to faster progression of blood cancers. Taurine — a non-essential amino acid that also occurs naturally in the bone marrow, brain, heart ...

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...

The Josep Carreras Institute becomes part of the Cancer Proteome Project, an international initiative for the study of malignant tumors The Spanish Minister of Science and Innovation, Diana Morant, ...

Researchers have demonstrated that some childhood leukemia originate during embryonic development, although they do not manifest after a few months after birth. Researchers from the Institute of ...

An international study conducted by the Alliance for Clinical Trials in Oncology and the Acute Myeloid Leukemia Cooperative Group reveals that age-based classifications in the treatment of acute ...

An international team of scientists has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth. AML cells prevent the synthesis of proteins that suppress their growth ...

CURE sat down with Dr. Kerry A. Rogers for an interview at the Hairy Cell Leukemia Foundation 2025 Conference, hosted in Bologna, Italy. We sat down with Dr. Kerry A. Rogers for an interview at the ...

The Josep Carreras Leukaemia Research Institute (IJC), the Josep Carreras Foundation (FJC), and the Sant Joan de Déu Research Institute (IRSJD) have agreed to develop a joint research programme on ...

Tyrosine kinases are protein enzymes that have many functions within cells, including cell signaling, growth, and division. Sometimes these enzymes can be overactive, which helps cancer cells survive ...